QOP
FSTX

Quinn Opportunity Partners’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Quinn Opportunity Partners’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-179,705
Closed -$1.14M – 251
2022
Q4 		$1.14M Buy
+179,705
New +$995K 0.14% 101

Quinn Opportunity Partners's FSTX Position: Q1 2023 in Review

Quinn Opportunity Partners sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 179,705 shares — an estimated $1.14M sold.

Quinn Opportunity Partners first reported a position in FSTX in Q4 2022 and held it in 1 quarter. The position peaked at $1.14M in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

  • Quinn Opportunity Partners reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Quinn Opportunity Partners sold 179,705 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $1.14M.
  • Quinn Opportunity Partners first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Quinn Opportunity Partners's F-star Therapeutics, Inc. Common Stock position peaked at $1.14M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Quinn Opportunity Partners's 13F filing for Q1 2023, filed 12 May 2023.